Onset of dementia is associated with apolipoprotein E ε4 in Down's syndrome

Annals of Neurology

Volumn 40, Issue 5, 1996, Pages 799-801

  Schupf, Nicole ^a,d   Kapell, Deborah ^a   Lee, Joseph H ^a,d   Zigman, Warren ^a   Canto, Basilisa ^d   Tycko, Benjamin ^b   Mayeux, Richard ^b,c,d  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c Columbia Univeristy ^*  (United States)

^d Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ADULT; ARTICLE; DEMENTIA; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DOWN SYNDROME; FEMALE; GENE EXPRESSION; GENETIC RISK; GENOTYPE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RISK FACTOR;

EID: 0029844434     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400518     Document Type: Article

References (15)

1. Mann DMA. Association between Alzheimer disease and Down syndrome. In: Berg JM, Karlinsky H, Holland AJ, eds. Alzheimer disease, Down syndrome and their relationship. Oxford: Oxford University Press, 1993:71-92
2. Wisniewski HM, Wegiel J, Popovitch ER. Age-associated development of diffuse and thioflavin-S-positive plaques in Down syndrome. Dev Brain Dysfunct 1994;7:330-339
3. Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 1989;46:849-853
4. Rumble B, Retallack R, Hilbich C, et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 1989;320:1446-1452
5. Strittmatter WJ, Saunders AM, Schemechel D, et al. Apolipoprotein E: high affinity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:1977-1981
6. Mayeux R, Stern Y, Tatemichi T, et al. The apolipoprotein ε4 allele in patients with Alzheimer's disease. Ann Neurol 1993; 34:752-754
7. Polvikoski T, Sulkava R, Haltia M, et al. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N Engl J Med 1995;333:1242-1247
8. Hyman BT, West HL, Rebeck GW, et al. Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc Natl Acad Sci USA 1995;92:3586-3590
9. Hardy J, Crook R, Perry R, et al. ApoE genotype and Down's syndrome. Lancet 1994;343:979-980
10. Royston MC, Mann D, Pickering-Brown S, et al. Apolipoprotein E ε2 allele promotes longevity and protects patients with Down's syndrome from dementia. Neuroreport 1994;5:2583-2585
11. van Gool WA, Evenhuis HM, van Duijn CM. A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Ann Neurol 1995;38:225-230
12. Nihira K, Forster R, Shellhaas M, Leland H. AAMD Adaptive Behavior Scale. Washington DC: American Association on Mental Deficiency, 1974
13. Saunders AM, Schmader K, Breitner JCS, et al. Apolipoprotein E ε4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming disease. Lancet 1993;342:710-711
14. Nicoll JAR, Roberts GW, Graham DI. Apolipoprotein E ε4 is associated with deposition of amyloid b-protein following head injury. Nature Med 1995;1:135-137
15. Harrington CR, Louwagie J, Rossau R, et al. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Am J Pathol 1994;145:1472-1484